{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:22:38Z","timestamp":1766524958812,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006368","name":"Universidad de las Palmas de Gran Canaria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006368","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Summary<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>We analyzed 5396 patients with fragility fracture, their inclusion by the FLS, and prescription of treatment. Thirty-four percent of potential cases were attended by the FLS, and at the healthcare level, the impact of FLS model resulted in an increase of treated patients from 20% in standard care to 41%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Patients with fragility fractures are at high risk of new fractures, with a negative impact on their quality of life, as well as higher mortality and costs for the health system, especially for hip fractures. Less than 20% of patients receive treatment (lifestyle advice, calcium, vitamin D, and bisphosphonate) after a fracture. The fracture liaison service (FLS) is the most effective model for secondary prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyze the incidence of fragility fractures in the area of Gran Canaria North and the impact of the FLS unit on the prevention of new fractures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients\u2009&gt;\u200950\u00a0years were attended at the emergency department for fractures of the proximal femur, proximal humerus, distal forearm, pelvis, or vertebra during the period 2018\u20132022 were included. A file was constructed containing demographic data, type of fracture, inclusion in the FLS, and the initiation of treatment to prevent new fractures. A sample of patients not treated at the FLS was selected for estimating the prophylaxis of fractures under standard care management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5396 patients were included, 74.2% women, with a mean age of 74\u00a0years. After excluding 558 traumatic fractures (10.3%), 318 (5.9%) deaths, and 167 (3.1%) cases due to a lack of criteria, the sample of potential patients who were candidates for FLS was 4353. This represented 80.6% of the initial sample, of which 1497 patients (34.4%) were attended at the unit. Factors independently associated with referral to the FLS were younger age (OR 0.97; 95% CI 0.97\u20130.98), female sex (OR 2.24; 95% CI 1.91\u20132.61), and humerus fracture (OR 1.34; 95% CI 1.16\u20131.55). Treatment to prevent fractures was verified in 1189 patients (79.4%) in the FLS group and in 585 (20.4%) of those with fragility fractures who were not included. At the healthcare level, the services provided by the FLS resulted in an increase in treated patients from 20% in standard care to 41% with the FLS model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In terms of treatment initiation to new fracture prevention at the healthcare level, the FLS achieved a twofold increase. The high incidence of fractures and the progressive aging of the population underline the effectiveness of the FLS secondary prevention model.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11657-025-01514-7","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:54:36Z","timestamp":1741348476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of the FLS model on patients with major fracture in Gran Canaria: 2018\u20132022 experience"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-6664","authenticated-orcid":false,"given":"Antonio","family":"Naranjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Sarmiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"6","key":"1514_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.berh.2010.10.003","volume":"24","author":"L S\u00e0nchez-Riera","year":"2010","unstructured":"S\u00e0nchez-Riera L, Wilson N, Kamalaraj N, Nolla JM, Kok C, Li Y et al (2010) Osteoporosis and fragility fractures. Best Pract Res Clin Rheumatol 24(6):793\u2013810","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"1514_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40520-019-01432-y","volume":"32","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Harvey NC, Johansson H, Vandenput L, Lorentzon M, McCloskey EV (2020) A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res 32(2):187\u2013196","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"1514_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82","journal-title":"Arch Osteoporos"},{"issue":"2","key":"1514_CR4","doi-asserted-by":"publisher","first-page":"221.e1","DOI":"10.1016\/j.amjmed.2015.09.020","volume":"129","author":"DL Kendler","year":"2016","unstructured":"Kendler DL, Bauer DC, Davison KS, Dian L, Hanley DA, Harris ST, McClung MR, Miller PD, Schousboe JT, Yuen CK, Lewiecki EM (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221.e1\u201310","journal-title":"Am J Med"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF01623271","volume":"3","author":"LJ Melton 3rd","year":"1993","unstructured":"Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O\u2019Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113\u2013119","journal-title":"Osteoporos Int"},{"key":"1514_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jbmr.5650070214","volume":"7","author":"C Cooper","year":"1992","unstructured":"Cooper C, Atkinson EJ, O\u2019Fallon WM, Melton LJ (1992) Incidence of clinically diagnosed verterbral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989. J Bone Miner Res 7:221\u2013227","journal-title":"J Bone Miner Res"},{"key":"1514_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","volume":"128","author":"MC Nevitt","year":"1998","unstructured":"Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR (1998) The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 128:793\u2013800","journal-title":"Ann Intern Med"},{"issue":"3","key":"1514_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5312\/wjo.v10.i3.166","volume":"10","author":"C Downey","year":"2019","unstructured":"Downey C, Kelly M, Quinlan JF (2019) Changing trends in the mortality rate at 1-year post hip fracture - a systematic review. World J Orthop 10(3):166\u2013175","journal-title":"World J Orthop"},{"issue":"4","key":"1514_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jbmr.1496","volume":"27","author":"A D\u00edez-P\u00e9rez","year":"2012","unstructured":"D\u00edez-P\u00e9rez A, Olmos JM, Nogu\u00e9s X, Sosa M, D\u00edaz-Curiel M, P\u00e9rez-Castrill\u00f3n JL et al (2012) Risk factors for prediction of inadequate response to antiresorptives. J Bone Miner Res 27(4):817\u2013882","journal-title":"J Bone Miner Res"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/jbmr.2882","volume":"31","author":"S Hawley","year":"2016","unstructured":"Hawley S, Leal J, Delmestri A, Prieto-Alhambra D, Arden NK, Cooper C et al (2016) Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis. J Bone Miner Res 31:2008\u20132015","journal-title":"J Bone Miner Res"},{"key":"1514_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00198-004-1675-5","volume":"15","author":"V Elliot-Gibson","year":"2004","unstructured":"Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767\u2013778","journal-title":"Osteoporos Int"},{"key":"1514_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/jgs.12507","volume":"61","author":"SK Liu","year":"2013","unstructured":"Liu SK, Munson JC, Bell JE, Zaha RL, Mecchella JN, Tosteson AN et al (2013) Quality of osteoporosis care of older medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc 61:1855\u20131862","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"1514_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.reuma.2018.09.004","volume":"15","author":"A Naranjo","year":"2019","unstructured":"Naranjo A, D\u00edaz P, Aguado MP, Arboleya L, Casado E, Casta\u00f1eda S et al (2019) Recommendations by the Spanish Society of Rheumatology on Osteoporosis. Reumatol Clin 15(4):188\u2013210","journal-title":"Reumatol Clin"},{"issue":"7","key":"1514_CR14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.rce.2021.12.007","volume":"222","author":"JA Riancho","year":"2022","unstructured":"Riancho JA, Peris P, Gonz\u00e1lez-Mac\u00edas J, P\u00e9rez-Castrill\u00f3n JL, SEIOMM Osteoporosis Guidelines Writing Group (2022) Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM). Rev Clin Esp (Barc). 222(7):432\u2013439","journal-title":"Rev Clin Esp (Barc)."},{"issue":"5","key":"1514_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.reuma.2013.12.007","volume":"10","author":"A Naranjo","year":"2014","unstructured":"Naranjo A, Ojeda-Bruno S, Cantarero AB, Abeledo JCQ, Henr\u00edquez-Hern\u00e1ndez LA, Rodr\u00edguez-Lozano C (2014) Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians. Reumatol Clin 10(5):299\u2013303","journal-title":"Reumatol Clin"},{"issue":"1","key":"1514_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11657-017-0373-9","volume":"12","author":"A Naranjo","year":"2017","unstructured":"Naranjo A, Fern\u00e1ndez-Conde S, Ojeda S, Torres-Hern\u00e1ndez L, Hern\u00e1ndez- Carballo C, Bernardos I et al (2017) Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture. Arch Osteoporos 12(1):112","journal-title":"Arch Osteoporos"},{"key":"1514_CR17","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/art.23093","volume":"57","author":"JT Harrington","year":"2007","unstructured":"Harrington JT, Lease J (2007) Osteoporosis disease management for fragility fracture patients: new understandings based on three years\u2019 experience with an osteoporosis care service. Arthritis Rheum 57:1502\u20131506","journal-title":"Arthritis Rheum"},{"key":"1514_CR18","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00198-011-1534-0","volume":"22","author":"AR McLellan","year":"2011","unstructured":"McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22:2083\u20132098","journal-title":"Osteoporos Int"},{"key":"1514_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023\u20131031","journal-title":"Osteoporos Int"},{"issue":"1","key":"1514_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11657-021-00925-6","volume":"16","author":"A Naranjo","year":"2021","unstructured":"Naranjo A, Molina A, Quevedo A, Rubi\u00f1o FJ, S\u00e1nchez-Alonso F, Rodr\u00edguez- Lozano C et al (2021) Fracture liaison service model: treatment persistence 5 years later. Arch Osteoporos 16(1):60","journal-title":"Arch Osteoporos"},{"key":"1514_CR21","unstructured":"Poblaci\u00f3n asignada. Memoria 2022. Hospital Universitario de Gran Canaria Doctor Negr\u00edn [Internet]. www3.gobiernodecanarias.org [cited 2024 May 28]. Available from: https:\/\/www3.gobiernodecanarias.org\/sanidad\/scs\/scs\/as\/gc\/29\/memorias\/22\/organizacion\/poblac_asig.htm"},{"issue":"Suppl 2","key":"1514_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00198-004-1702-6","volume":"16","author":"O Johnell","year":"2005","unstructured":"Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3-7","journal-title":"Osteoporos Int"},{"key":"1514_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0149-2918(99)80022-8","volume":"21","author":"PJ Meunier","year":"1999","unstructured":"Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R et al (1999) Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther. 21:1025\u201344","journal-title":"Clin Ther."},{"issue":"4","key":"1514_CR24","doi-asserted-by":"publisher","first-page":"101380","DOI":"10.1016\/j.regg.2023.101380","volume":"58","author":"I Miranda","year":"2023","unstructured":"Miranda I, Ferr\u00e1s-Tarrag\u00f3 J, Colado J, Sang\u00fcesa-Nebot MJ, Dom\u00e9nech J (2023) Impacto de la pandemia por COVID-19 y el confinamiento estricto de la poblaci\u00f3n en la incidencia de fractura de cadera en Espa\u00f1a. Una revisi\u00f3n sistem\u00e1tica [Impact of the COVID-19 pandemic and the strict population confinement on hip fracture incidence in Spain: A systematic review]. Rev Esp Geriatr Gerontol. 58(4):101380","journal-title":"Rev Esp Geriatr Gerontol."},{"issue":"2","key":"1514_CR25","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bone.2007.10.001","volume":"42","author":"ML Alvarez-Nebreda","year":"2008","unstructured":"Alvarez-Nebreda ML, Jim\u00e9nez AB, Rodr\u00edguez P, Serra JA (2008) Epidemiology of hip fracture in the elderly in Spain. Bone 42(2):278\u2013285. https:\/\/doi.org\/10.1016\/j.bone.2007.10.001","journal-title":"Bone"},{"issue":"1","key":"1514_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11657-024-01406-2","volume":"19","author":"D Toledo","year":"2024","unstructured":"Toledo D, Mayordomo-Cava J, Jurado P, D\u00edaz A, Serra-Rexach JA (2024) Trends in hip fracture rates in Spain from 2001 to 2018. Arch Osteoporos 19(1):57. https:\/\/doi.org\/10.1007\/s11657-024-01406-2","journal-title":"Arch Osteoporos"},{"issue":"4","key":"1514_CR27","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s00198-014-3002-0","volume":"26","author":"M Sosa","year":"2015","unstructured":"Sosa M, Saavedra P, de Tejada MJ, Navarro M, Cabrera D, Melton LJ 3rd (2015) Trends in the incidence of hip fracture in Gran Canaria, Canary Islands, Spain: 2007\u20132011 versus 1989\u20131993. Osteoporos Int 26(4):1361\u20131366. https:\/\/doi.org\/10.1007\/s00198-014-3002-0","journal-title":"Osteoporos Int"},{"key":"1514_CR28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.2180","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Patrick AR, Schousboe J, Losina E (2014) The potential economic benefits of improved post-fracture care: a cost-effectiveness analysis of a fracture liaison service in the US health care system. J Bone Miner Res 29:1667\u20131674","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1514_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11657-020-00729-0","volume":"15","author":"A Naranjo","year":"2020","unstructured":"Naranjo A, Molina A, Sep\u00falveda C, Rubi\u00f1o FJ, Mart\u00edn N, Ojeda S (2020) The evolution of an FLS in search of excellence: the experience of Gran Canaria. Arch Osteoporos 15(1):108","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1514_CR30","doi-asserted-by":"publisher","first-page":"9373","DOI":"10.1038\/s41598-022-13465-x","volume":"12","author":"A Naranjo","year":"2022","unstructured":"Naranjo A, Molina A, Quevedo A, Rubi\u00f1o FJ, S\u00e1nchez-Alonso F, Rodr\u00edguez-Lozano C et al (2022) Long-term persistence of treatment after hip fracture in a fracture liaison service. Sci Rep 12(1):9373","journal-title":"Sci Rep"},{"issue":"14","key":"1514_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CEOR.S350790","volume":"22","author":"A Naranjo","year":"2022","unstructured":"Naranjo A, Prieto-Alhambra D, S\u00e1nchez-Mart\u00edn J, P\u00e9rez-Mitru A, Brosa M (2022) Cost-Effectiveness analysis of Fracture Liaison Services compared with standard of care in the secondary prevention of fragility fractures in Spain. Clinicoecon Outcomes Res 22(14):249\u2013264","journal-title":"Clinicoecon Outcomes Res"},{"key":"1514_CR32","doi-asserted-by":"publisher","first-page":"115838","DOI":"10.1016\/j.bone.2020.115838","volume":"144","author":"A Delbar","year":"2021","unstructured":"Delbar A, Pflimlin A, Delabri\u00e8re I, Ternynck C, Chantelot C, Puisieux F, Cortet B, Paccou J (2021) Persistence with osteoporosis treatment in patients from the Lille University Hospital Fracture Liaison Service. Bone 144:115838. https:\/\/doi.org\/10.1016\/j.bone.2020.115838","journal-title":"Bone"},{"issue":"1","key":"1514_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11657-020-00736-1","volume":"15","author":"DJ Scholten 2nd","year":"2020","unstructured":"Scholten DJ 2nd, Bray JK, Wang KY, Lake AF, Emory CL (2020) Implementation of a fracture liaison service and its effects on osteoporosis treatment adherence and secondary fracture at a tertiary care academic health system. Arch Osteoporos 15(1):80. https:\/\/doi.org\/10.1007\/s11657-020-00736-1","journal-title":"Arch Osteoporos"},{"issue":"1","key":"1514_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11657-019-0675-1","volume":"15","author":"P Makras","year":"2020","unstructured":"Makras P, Babis GC, Chronopoulos E, Karachalios T, Kazakos K, Paridis D, Potoupnis M, Tzavellas AN, Valkanis C, Kosmidis C (2020) Experience gained from the implementation of the fracture liaison service in Greece. Arch Osteoporos 15(1):12. https:\/\/doi.org\/10.1007\/s11657-019-0675-1","journal-title":"Arch Osteoporos"},{"key":"1514_CR35","unstructured":"National Hip Fracture Database. Royal College of Physicians. https:\/\/www.nhfd.co.uk\/2023report. Accessed July 29th 2024"},{"key":"1514_CR36","doi-asserted-by":"publisher","unstructured":"Chandrasoma D, Chiu S, Niddrie F, Major G (2024) Should major trauma fractures be part of a fracture liaison service\u2019s remit: a cost-benefit estimate. Osteoporos Int.\u00a0https:\/\/doi.org\/10.1007\/s00198-024-07134-0","DOI":"10.1007\/s00198-024-07134-0"},{"issue":"1","key":"1514_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11657-023-01213-1","volume":"18","author":"R Izquierdo-Avino","year":"2023","unstructured":"Izquierdo-Avino R, Cebollada-Gadea L, Jordan-Jarque M, Bordonaba-Bosque D, L\u00f3pez-Cabanas JA (2023) Risk of osteoporotic fracture and refracture: the importance of index fracture site. Arch Osteoporos 18(1):27. https:\/\/doi.org\/10.1007\/s11657-023-01213-1","journal-title":"Arch Osteoporos"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01514-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01514-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01514-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:17:43Z","timestamp":1766524663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01514-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01514-7","relation":{},"ISSN":["1862-3514"],"issn-type":[{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by an ethics and research committee with the code NAR-OST-2011\u201302.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Antonio Naranjo has received support for registration and travel to congresses provided by Amgen Eu-ropa and Alfasigma SpA and fees from Amgen Europa GmbH and UCB for conferences. Soledad Ojeda has received support for registration and travel to congresses provided by Amgen Europe and honoraria for speaking engagements from Amgen Europa GmbH and UCB. Laura C\u00e1ceres has received support for registration and travel to congresses provided by Amgen Europe and honoraria for speaking engagements from Amgen Europa GmbH. Cristian Sarmiento and Amparo Molina declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}